GB864718A - Improvements in or relating to the purification of bacitracin - Google Patents

Improvements in or relating to the purification of bacitracin

Info

Publication number
GB864718A
GB864718A GB19774/59A GB1977459A GB864718A GB 864718 A GB864718 A GB 864718A GB 19774/59 A GB19774/59 A GB 19774/59A GB 1977459 A GB1977459 A GB 1977459A GB 864718 A GB864718 A GB 864718A
Authority
GB
United Kingdom
Prior art keywords
resins
amberlite
bacitracin
acid groups
sulphonic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB19774/59A
Inventor
Arlen Rector Elliott
Francis William Chornock
Eli Zinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commercial Solvents Corp
Original Assignee
Commercial Solvents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commercial Solvents Corp filed Critical Commercial Solvents Corp
Priority to GB19774/59A priority Critical patent/GB864718A/en
Publication of GB864718A publication Critical patent/GB864718A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Bacitracin is purified by passing an aqueous solution of bacitracin having a pH of 2 to 10 through a strongly acidic cation exchange resin and a weakly basic anion exchange resin, the bacitracin being neither absorbed on said resins nor eluted therefrom, and drying the resulting solution to obtain solid bacitracin. A fermentation broth is clarified and the pH adjusted first to pH 3,5 and then to pH 7,5 to precipitate impurities. The exchange resins are in the free acid and free base form. The aqueous solution of bacitracin may be passed down a column of exchange resin in any order or simultaneously i.e. a column of mixed resins may be used. The cation exchange resins may be those which contain nuclear sulphonic acid groups or methylene sulphonic acid groups e.g. phenol formaldehyde resins containing nuclear sulphonic acid groups or sulphonated aromatic hydrocarbon polymers such as sulphonated polystyrene resins e.g. " Amberlite " (Registered Trade Mark) 1R-120. The anion exchange resins are weak amine or mixed amine type phenol formaldehyde resins e.g. Amberlite 1R-4B and Amberlite 1R-45. Mixed resins are Amberlite MB-4, a mixture of Amberlite 1R-120 and Amberlite 1R-45.
GB19774/59A 1959-06-09 1959-06-09 Improvements in or relating to the purification of bacitracin Expired GB864718A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB19774/59A GB864718A (en) 1959-06-09 1959-06-09 Improvements in or relating to the purification of bacitracin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB19774/59A GB864718A (en) 1959-06-09 1959-06-09 Improvements in or relating to the purification of bacitracin

Publications (1)

Publication Number Publication Date
GB864718A true GB864718A (en) 1961-04-06

Family

ID=10135003

Family Applications (1)

Application Number Title Priority Date Filing Date
GB19774/59A Expired GB864718A (en) 1959-06-09 1959-06-09 Improvements in or relating to the purification of bacitracin

Country Status (1)

Country Link
GB (1) GB864718A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105504020A (en) * 2016-01-23 2016-04-20 雅赛利(台州)制药有限公司 Pharmaceutical grade bacitracin and preparing device thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105504020A (en) * 2016-01-23 2016-04-20 雅赛利(台州)制药有限公司 Pharmaceutical grade bacitracin and preparing device thereof
CN105504020B (en) * 2016-01-23 2019-12-20 雅赛利(台州)制药有限公司 Pharmaceutical grade bacitracin and preparation device thereof

Similar Documents

Publication Publication Date Title
KR840007438A (en) Method for Purifying Anthracyclinone Glucoside
GB933823A (en) Process for the preparation of trimethylolalkanes having improved use characteristics and products obtained thereby
GB959675A (en) The antibiotic actinospectacin and a process for the production thereof
GB864718A (en) Improvements in or relating to the purification of bacitracin
FR1425320A (en) Process for the purification of nitro derivatives of aromatic hydrocarbons
GB976568A (en) A process for the production of amphoteric ion exchange resins
GB1103709A (en) Purification of nicotinamide-adenine-dinucleotide
GB1224768A (en) Purification of antibiotic 833a
GB960049A (en) Improvements in or relating to cation exchange resins
GB810566A (en) Purification of bacillus subtilis protease
GB847770A (en) Improvements in the purification of dimethylformamide
ATE77394T1 (en) BORON RESINS WITH HIGH SELECTIVE ABSORPTION EFFECT.
GB897006A (en) Improvements in or relating to mixtures of ion-exchange resins
JPS5291819A (en) Purification of aqueous solutions of acrylamide
GB1060044A (en) Improvements in and relating to methods of preparing a porous surface for finishing
GB757090A (en) Purification of antibiotic 106í¬7
ES297145A1 (en) A method of purifying a dilutable solution of sacarosa (Machine-translation by Google Translate, not legally binding)
JPS5770858A (en) Purification of compound containing both amino group and sulfonic group
GB947797A (en) A method of recovering glutamic acid from fermentation broths
GB778061A (en) Improvements in or relating to recovery of uranium from naturally occurring materials
GB620679A (en) Tanning agents and method for preparing same
GB812815A (en) Improvements relating to the recovery of uranium from solutions
GB1409775A (en) Purification method for trh
ES389055A1 (en) Antibiotic purification procedure. (Machine-translation by Google Translate, not legally binding)
SE310632B (en)